These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 27866969)
1. Overexpression of CD109 in the Epidermis Differentially Regulates ALK1 Versus ALK5 Signaling and Modulates Extracellular Matrix Synthesis in the Skin. Vorstenbosch J; Nguyen CM; Zhou S; Seo YJ; Siblini A; Finnson KW; Bizet AA; Tran SD; Philip A J Invest Dermatol; 2017 Mar; 137(3):641-649. PubMed ID: 27866969 [TBL] [Abstract][Full Text] [Related]
2. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma. Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317 [TBL] [Abstract][Full Text] [Related]
3. Transgenic mice overexpressing CD109 in the epidermis display decreased inflammation and granulation tissue and improved collagen architecture during wound healing. Vorstenbosch J; Gallant-Behm C; Trzeciak A; Roy S; Mustoe T; Philip A Wound Repair Regen; 2013; 21(2):235-46. PubMed ID: 23438099 [TBL] [Abstract][Full Text] [Related]
4. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes. Finnson KW; Parker WL; ten Dijke P; Thorikay M; Philip A J Bone Miner Res; 2008 Jun; 23(6):896-906. PubMed ID: 18333754 [TBL] [Abstract][Full Text] [Related]
5. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts. Man XY; Finnson KW; Baron M; Philip A Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1. Zhang H; Du L; Zhong Y; Flanders KC; Roberts JD Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L615-L627. PubMed ID: 28642261 [TBL] [Abstract][Full Text] [Related]
7. CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis. Litvinov IV; Bizet AA; Binamer Y; Jones DA; Sasseville D; Philip A Exp Dermatol; 2011 Aug; 20(8):627-32. PubMed ID: 21539622 [TBL] [Abstract][Full Text] [Related]
8. CD109, a novel TGF-β antagonist, decreases fibrotic responses in a hypoxic wound model. Winocour S; Vorstenbosch J; Trzeciak A; Lessard L; Philip A Exp Dermatol; 2014 Jul; 23(7):475-9. PubMed ID: 24815824 [TBL] [Abstract][Full Text] [Related]
9. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function. Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545 [TBL] [Abstract][Full Text] [Related]
10. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. Blaney Davidson EN; Remst DF; Vitters EL; van Beuningen HM; Blom AB; Goumans MJ; van den Berg WB; van der Kraan PM J Immunol; 2009 Jun; 182(12):7937-45. PubMed ID: 19494318 [TBL] [Abstract][Full Text] [Related]
11. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. Goumans MJ; Valdimarsdottir G; Itoh S; Rosendahl A; Sideras P; ten Dijke P EMBO J; 2002 Apr; 21(7):1743-53. PubMed ID: 11927558 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways. Pannu J; Nakerakanti S; Smith E; ten Dijke P; Trojanowska M J Biol Chem; 2007 Apr; 282(14):10405-13. PubMed ID: 17317656 [TBL] [Abstract][Full Text] [Related]
14. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Goumans MJ; Valdimarsdottir G; Itoh S; Lebrin F; Larsson J; Mummery C; Karlsson S; ten Dijke P Mol Cell; 2003 Oct; 12(4):817-28. PubMed ID: 14580334 [TBL] [Abstract][Full Text] [Related]
15. The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors. Bizet AA; Liu K; Tran-Khanh N; Saksena A; Vorstenbosch J; Finnson KW; Buschmann MD; Philip A Biochim Biophys Acta; 2011 May; 1813(5):742-53. PubMed ID: 21295082 [TBL] [Abstract][Full Text] [Related]
16. Epidermal hyperplasia and appendage abnormalities in mice lacking CD109. Mii S; Murakumo Y; Asai N; Jijiwa M; Hagiwara S; Kato T; Asai M; Enomoto A; Ushida K; Sobue S; Ichihara M; Takahashi M Am J Pathol; 2012 Oct; 181(4):1180-9. PubMed ID: 22846721 [TBL] [Abstract][Full Text] [Related]
17. Smad2/Smad3 in endothelium is indispensable for vascular stability via S1PR1 and N-cadherin expressions. Itoh F; Itoh S; Adachi T; Ichikawa K; Matsumura Y; Takagi T; Festing M; Watanabe T; Weinstein M; Karlsson S; Kato M Blood; 2012 May; 119(22):5320-8. PubMed ID: 22498737 [TBL] [Abstract][Full Text] [Related]
18. Canonical Wnt signaling skews TGF-β signaling in chondrocytes towards signaling via ALK1 and Smad 1/5/8. van den Bosch MH; Blom AB; van Lent PL; van Beuningen HM; Blaney Davidson EN; van der Kraan PM; van den Berg WB Cell Signal; 2014 May; 26(5):951-8. PubMed ID: 24463008 [TBL] [Abstract][Full Text] [Related]
19. Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma. Sonnylal S; Denton CP; Zheng B; Keene DR; He R; Adams HP; Vanpelt CS; Geng YJ; Deng JM; Behringer RR; de Crombrugghe B Arthritis Rheum; 2007 Jan; 56(1):334-44. PubMed ID: 17195237 [TBL] [Abstract][Full Text] [Related]
20. Distinct regulation of gene expression in human endothelial cells by TGF-beta and its receptors. Wu X; Ma J; Han JD; Wang N; Chen YG Microvasc Res; 2006 Jan; 71(1):12-9. PubMed ID: 16405919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]